若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

EasySep™人CD56正选试剂盒 II

人CD56+细胞的免疫磁珠正选

产品号 #(选择产品)

产品号 #17855_C

人CD56+细胞的免疫磁珠正选

产品优势

  • 快捷、操作简单    
  • 纯度高达98%
  • 无需分离柱     

产品组分包括

  • EasySep™人CD56正选试剂盒 II(产品号 #17855)
    • EasySep™人CD56正选抗体混合物 II,1 mL
    • EasySep™ Dextran RapidSpheres™ 50100 磁珠,1 mL
  • RoboSep™人CD56正选试剂盒 II(产品号 #17855RF)
    • EasySep™人CD56正选抗体混合物 II,1 mL
    • EasySep™ Dextran RapidSpheres™ 50100 磁珠,1 mL
    • RoboSep™ 缓冲液(产品号 #20104)
    • RoboSep™过滤吸头(产品号 #20125)
专为您的实验方案打造的产品
要查看实验方案所需的所有配套产品,请参阅《实验方案与技术文档》

总览

使用EasySep™人CD56正选试剂盒 II,通过免疫磁珠正选 ,从新鲜或冻存的外周血单个核细胞或人骨骼肌(成肌细胞和成纤维细胞)培养样本中分离高纯度的人CD56+细胞。EasySep™结合了单克隆抗体的特异性和无柱磁性系统的简便性,迄今已广泛应用于发表的研究中超过20年。    

在此EasySep™正选过程中,目的细胞被识别CD56的抗体复合物及磁珠结合标记。该试剂盒中还含有人Fc受体阻断剂 ,可最大程度减少非特异性结合。使用EasySep™磁极分离标记的目的细胞,只需倾倒或吸弃非目的细胞,目标细胞则保留在管中。经磁珠分选后的目的CD56+细胞可直接用于下游应用,如流式细胞术、细胞培养或DNA/RNA提取。CD56抗原表达于NK细胞、NKT细胞和人成肌细胞表面 。

该产品可替代EasySep™人CD56细胞正选试剂盒 (产品号 #18055 ) 以进行更快的细胞分选。

了解更多关于免疫磁珠EasySep™技术的工作原理,或如何通过RoboSep™实现全自动化免疫磁珠细胞分选。或选择即用型、符合伦理规范的冻存人外周血CD56+原代细胞,该细胞通过EasySep™人CD56正选试剂盒 II分离获得。探索更多优化您实验流程的产品     ,包括培养基、添加剂、抗体等。

磁极兼容性
• EasySep™磁极(产品号 #18000) • “The Big Easy” EasySep™磁极(产品号 #18001) • EasyPlate™ EasySep™磁极(产品号 #18102) • EasyEights™ EasySep™磁极(产品号 #18103) • RoboSep™-S(产品号 #21000)
 
分类
细胞分选试剂盒
 
细胞类型
NK 细胞
 
种属

 
样本来源
其它细胞系,PBMC
 
分选方法
正选
 
应用
细胞分选
 
品牌
EasySep,RoboSep
 
研究领域
嵌合体,免疫
 

实验数据

Typical EasySep™ Human CD56 Positive Selection Profile

Figure 1. Typical EasySep™ Human CD56 Positive Selection Kit II (Catalog #17855)

Starting with human PBMCs, the CD56+ cell content of the isolated fraction is typically 96.3 ± 2.4% (mean ± SD), using the purple EasySep™ Magnet. In the above example, the purities of the start and final isolated fractions are 8.0% and 98.5%, respectively.

FACS Data for Anti-Human CD56 Antibody, Clone HCD56, Alexa Fluor® 488-Conjugated

Figure 2. FACS Data for Anti-Human CD56 Antibody, Clone HCD56, Alexa Fluor® 488-Conjugated

(A) Flow cytometry analysis of human peripheral blood mononuclear cells (PBMCs) labeled with Anti-Human CD56 Antibody, Clone HCD56, Alexa Fluor® (Catalog #60021AD) and Anti-Human CD45 Antibody, Clone HI30, APC (Catalog #60018AZ).

(B) Flow cytometry analysis of human PBMCs processed with the EasySep™ Human CD56 Positive Selection Kit (Catalog #17885) and labeled with Anti-Human CD56 Clone HCD56, Alexa Fluor® 488. Histograms show labeling of PBMCs (Start) and isolated cells (Isolated). Labeling of start cells with a mouse IgG1, kappa Alexa Fluor® 488 isotype control antibody is shown (solid line histogram).

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明,或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
17855
Lot #
1000087747 or higher
Language
English
Catalog #
17855
Lot #
All
Language
English
Catalog #
17855RF
Lot #
All
Language
English
Catalog #
17855RF
Lot #
1000087747 or higher
Language
English
Document Type
Safety Data Sheet 1
Catalog #
17855
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
17855
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
17855RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
17855RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
17855RF
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计,适用于工作流程中的高亮阶段。探索这些工作流程,了解更多我们为各研究领域提供的其他配套产品。

相关材料与文献

技术资料 (11)

常见问题

Can EasySep™ be used for either positive or negative selection?

Yes. The EasySep™ kits use either a negative selection approach by targeting and removing unwanted cells or a positive selection approach targeting desired cells. Depletion kits are also available for the removal of cells with a specific undesired marker (e.g. GlyA).

How does the separation work?

Magnetic particles are crosslinked to cells using Tetrameric Antibody Complexes (TAC). When placed in the EasySep™ Magnet, labeled cells migrate to the wall of the tube. The unlabeled cells are then poured off into a separate fraction.

Which columns do I use?

The EasySep™ procedure is column-free. That's right - no columns!

How can I analyze the purity of my enriched sample?

The Product Information Sheet provided with each EasySep™ kit contains detailed staining information.

Can EasySep™ separations be automated?

Yes. RoboSep™, the fully automated cell separator, automates all EasySep™ labeling and cell separation steps.

Can EasySep™ be used to isolate rare cells?

Yes. We recommend a cell concentration of 2x108 cells/mL and a minimum working volume of 100 µL. Samples containing 2x107 cells or fewer should be suspended in 100 µL of buffer.

Are the EasySep™ magnetic particles FACS-compatible?

Yes, the EasySep™ particles are flow cytometry-compatible, as they are very uniform in size and about 5000X smaller than other commercially available magnetic beads used with column-free systems.

Can the EasySep™ magnetic particles be removed after enrichment?

No, but due to the small size of these particles, they will not interfere with downstream applications.

Can I alter the separation time in the magnet?

Yes; however, this may impact the kit's performance. The provided EasySep™ protocols have already been optimized to balance purity, recovery and time spent on the isolation.

For positive selection, can I perform more than 3 separations to increase purity?

Yes, the purity of targeted cells will increase with additional rounds of separations; however, cell recovery will decrease.

How does the binding of the EasySep™ magnetic particle affect the cells? is the function of positively selected cells altered by the bound particles?

Hundreds of publications have used cells selected with EasySep™ positive selection kits for functional studies. Our in-house experiments also confirm that selected cells are not functionally altered by the EasySep™ magnetic particles.

If particle binding is a key concern, we offer two options for negative selection. The EasySep™ negative selection kits can isolate untouched cells with comparable purities, while RosetteSep™ can isolate untouched cells directly from whole blood without using particles or magnets.

文献 (2)

PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals. R. Fromentin et al. Nature communications 2019 feb

Abstract

HIV persists in latently infected CD4+ T cells during antiretroviral therapy (ART). Immune checkpoint molecules, including PD-1, are preferentially expressed at the surface of persistently infected cells. However, whether PD-1 plays a functional role in HIV latency and reservoir persistence remains unknown. Using CD4+ T cells from HIV-infected individuals, we show that the engagement of PD-1 inhibits viral production at the transcriptional level and abrogates T-cell receptor (TCR)-induced HIV reactivation in latently infected cells. Conversely, PD-1 blockade with the monoclonal antibody pembrolizumab enhances HIV production in combination with the latency reversing agent bryostatin without increasing T cell activation. Our results suggest that the administration of immune checkpoint blockers to HIV-infected individuals on ART may facilitate latency disruption.
Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. A. H. Mandarano et al. The Journal of clinical investigation 2019 dec

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease with no known cause or mechanism. There is an increasing appreciation for the role of immune and metabolic dysfunction in the disease. ME/CFS has historically presented in outbreaks, often has a flu-like onset, and results in inflammatory symptoms. Patients suffer from severe fatigue and post-exertional malaise. There is little known about the metabolism of specific immune cells in ME/CFS patients. To investigate immune metabolism in ME/CFS, we isolated CD4+ and CD8+ T cells from 53 ME/CFS patients and 45 healthy controls. We analyzed glycolysis and mitochondrial respiration in resting and activated T cells, along with markers related to cellular metabolism, and plasma cytokines. We found that ME/CFS CD8+ T cells have reduced mitochondrial membrane potential compared to healthy controls. Both CD4+ and CD8+ T cells from ME/CFS patients had reduced glycolysis at rest, while CD8+ T cells also had reduced glycolysis following activation. ME/CFS patients had significant correlations between measures of T cell metabolism and plasma cytokine abundance that differed from healthy control subjects. Our data indicate that patients have impaired T cell metabolism consistent with ongoing immune alterations in ME/CFS that may illuminate the mechanism behind this disease.

更多信息

更多信息
种属 Human
Magnet Compatibility • EasySep™ Magnet (Catalog #18000) • “The Big Easy” EasySep™ Magnet (Catalog #18001) • EasyPlate™ EasySep™ Magnet (Catalog #18102) • EasyEights™ EasySep™ Magnet (Catalog #18103) • RoboSep™-S (Catalog #21000)
样本来源 Other, PBMC
Selection Method Positive
标记抗体
质量保证:

产品仅供研究使用,不用于针对人或动物的诊断或治疗。 欲获悉更多关于STEMCELL的质控信息,请访问 STEMCELL.CN/COMPLIANCE.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.